2019
DOI: 10.1017/s0022215119002305
|View full text |Cite
|
Sign up to set email alerts
|

Tranexamic acid has no advantage in head and neck surgical procedures: a randomised, double-blind, controlled clinical trial

Abstract: ObjectiveTo assess the effect of tranexamic acid in head and neck surgical procedures.MethodsA prospective, double-blind and randomised, parallel group, placebo-controlled clinical trial was conducted. Ninety-two patients undergoing various head and neck surgical procedures were randomised. Subjects received seven infusions of coded drugs (tranexamic acid or normal saline) starting at the time of skin closure. Haematological, biochemical, blood loss and other parameters were observed by the staff, who were bli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(13 citation statements)
references
References 13 publications
0
13
0
Order By: Relevance
“…investigate the effect of tranexamic acid (compared to saline placebo) on post-operative blood loss in various head and neck surgical procedures (including thyroid and parotid surgery, and neck dissections, with or without primary tumour excision) in a double-blinded, randomised, controlled trial involving 92 patients. 4 Although this prospective, randomised, placebo-controlled clinical trial found a reduction in post-operative drain volume in the tranexamic acid group, the difference was not statistically significant between the various head and neck surgical procedure groups. Despite confirming the null hypothesis, this is a useful study that supports previously published data in this patient group and confirms there does not appear to be a significant benefit of the use of tranexamic acid in this group of patients.…”
mentioning
confidence: 69%
“…investigate the effect of tranexamic acid (compared to saline placebo) on post-operative blood loss in various head and neck surgical procedures (including thyroid and parotid surgery, and neck dissections, with or without primary tumour excision) in a double-blinded, randomised, controlled trial involving 92 patients. 4 Although this prospective, randomised, placebo-controlled clinical trial found a reduction in post-operative drain volume in the tranexamic acid group, the difference was not statistically significant between the various head and neck surgical procedure groups. Despite confirming the null hypothesis, this is a useful study that supports previously published data in this patient group and confirms there does not appear to be a significant benefit of the use of tranexamic acid in this group of patients.…”
mentioning
confidence: 69%
“…According to the results, there was no statistically significant relationship between the control and experimental groups of Group 1 and Group 2 regarding BL during and after surgery, which was consistent with the results of the present study in terms of BL after surgery but inconsistent with the present results in terms of BL during surgery. [12]…”
Section: Discussionmentioning
confidence: 99%
“…do not differ significantly with the use of TXA and continue to present as a major challenge. into two main categories-8 out of the 16 studies were identified to be major H&N surgical studies [6][7][8][18][19][20][21][22] while the other 8 were tonsillectomy studies. [23][24][25][26][27][28][29][30] The characteristics of the studies for the tonsillectomy studies are defined in Table 4 and for the H&N studies in Table 5, including a breakdown of the type of H&N operations undertaken.…”
Section: The Rates Of Secondary Posttonsillectomy Haemorrhagementioning
confidence: 99%
“…The use of TXA in H&N surgery has been investigated by multiple randomised controlled trials (RCTs). [6][7][8] TXA is a synthetic analogue of the lysine amino acid that competitively and reversibly binds to plasminogen, 9 rendering it unavailable for lysine residues, 9 thereby preventing the degradation of the fibrin clot. The H&N studies looking at TXA [6][7][8] have demonstrated variable results.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation